Estimating averted COVID-19 cases, hospitalisations, intensive care unit admissions and deaths by COVID-19 vaccination, Italy, January-September 2021

Euro Surveill. 2021 Nov;26(47):2101001. doi: 10.2807/1560-7917.ES.2021.26.47.2101001.

Abstract

We assessed the impact of COVID-19 vaccination in Italy, by estimating numbers of averted COVID-19 cases, hospitalisations, ICU admissions and deaths between January and September 2021, by age group and geographical macro areas. Timing and speed of vaccination programme implementation varied slightly between geographical areas, particularly for older adults. We estimated that 445,193 (17% of expected; range: 331,059-616,054) cases, 79,152 (32%; range: 53,209-148,756) hospitalisations, 9,839 ICU admissions (29%; range: 6,434-16,276) and 22,067 (38%; range: 13,571-48,026) deaths were prevented by vaccination.

Keywords: Italy; SARS-CoV-2; averted events; impact; vaccines.

MeSH terms

  • Aged
  • COVID-19 Vaccines*
  • COVID-19*
  • Hospitalization
  • Humans
  • Intensive Care Units
  • Italy / epidemiology
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines